SINOVAC BIOTECH LTD Deferred Tax Assets, Operating Loss Carryforwards
SINOVAC BIOTECH LTD (SVA) had Deferred Tax Assets, Operating Loss Carryforwards of $374.11 million as of 2025-12-31, per its 20-F filed 2026-06-05.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-06-05
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $374.11M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $257.15M; Deferred Tax Assets, Operating Loss Carryforwards as first filed $259.65M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $179.77M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $23.53M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $374.11M 20-F · filed 2026-06-05 | |
| 2024-12-31 | $257.15M 20-F · filed 2026-06-05 | $259.65M 20-F · filed 2026-04-30 |
| 2023-12-31 | $179.77M 20-F · filed 2026-04-30 | |
| 2022-12-31 | $23.53M 20-F · filed 2026-04-30 | |
| 2021-12-31 | $12.69M 20-F · filed 2026-04-30 | |
| 2013-12-31 | $10.54M 20-F · filed 2014-04-16 | |
| 2012-12-31 | $10.31M 20-F · filed 2014-04-16 | $10.32M 20-F/A · filed 2013-05-23 |
| 2011-12-31 | $2.06M 20-F/A · filed 2013-05-23 |